Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | B cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 [4] 11, 13, 51, 300 💬
|
2 | B cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 [1] 300 💬
|
3 | Epstein-Barr virus infection 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 [4] 11, 13, 51, 300 💬
|
4 | Epstein-Barr virus infection 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 [1] 300 💬
|
5 | Hematopoietic cell lineage 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 [4] 11, 13, 51, 300 💬
|
6 | Hematopoietic cell lineage 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 [1] 300 💬
|
7 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 [4] 11, 13, 51, 300 💬
|
8 | PI3K-Akt signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 [1] 300 💬
|
9 | Primary immunodeficiency 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 [4] 11, 13, 51, 300 💬
|
10 | Primary immunodeficiency 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
CD19 [1] CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 [1] 300 💬
|